Hodgkin Lymphoma

• CLINICAL_TRIALS trial_result · 2008-07-10
  Clinical Trial Update: Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma [Phase 2]

  This Phase 2 trial of bortezomib (Velcade) in combination with dexamethasone for relapsed Hodgkin lymphoma has been terminated.

• CLINICAL_TRIALS trial_result · 2008-06-20
  Clinical Trial Update: Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training [Phase 2]

  Phase 2 trial completion evaluating an antioxidant in cancer-cachectic patients undergoing exercise training.

• CLINICAL_TRIALS trial_result · 2008-05-09
  Clinical Trial Update: Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]

  A clinical trial update describing a Phase 1/2 study evaluating the safety and efficacy of TNX-650 for refractory Hodgkin lymphoma.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas [Phase 2]

  This Phase II randomized trial compares EPOCH II alone to EPOCH II with immunotherapy in Hodgkin lymphoma and Non-Hodgkin lymphoma; the stud…

• CLINICAL_TRIALS trial_result · 2008-02-28
  Clinical Trial Update: Pegfilgrastim PBPC Mobilization Study [Phase 2]

  Completed Phase 2 clinical trial sponsored by Amgen evaluating pegfilgrastim for peripheral blood progenitor cell mobilization in patients w…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-01-28
  FDA Approved: BLEOMYCIN — Original Application (Fresenius Kabi USA, LLC)

  The FDA approved Fresenius Kabi USA's original ANDA for bleomycin sulfate, making a generic version of bleomycin available. Bleomycin is an …

• CLINICAL_TRIALS trial_result · 2007-11-02
  Clinical Trial Update: Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

  Completed clinical trial investigating pulmonary function at presentation and during follow-up in children aged 3-7 years with hematologic c…

• CLINICAL_TRIALS trial_result · 2007-10-15
  Clinical Trial Update: Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies [Phase 1]

  This is a completed Phase 1 study evaluating TPI-287 administered every 21 days in patients with advanced malignancies, including Hodgkin ly…

• CLINICAL_TRIALS trial_result · 2007-08-15
  Clinical Trial Update: Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma [Phase 2]

  Phase 2 study evaluating ABT-510 for refractory lymphoma has completed. The provided snippet references the trial status but does not includ…

• CLINICAL_TRIALS trial_result · 2007-05-04
  Clinical Trial Update: Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [Phase 3]

  Phase 3 trial update evaluating safety and efficacy of PN-152,243 and PN-196,444 in preventing thrombocytopenia in patients with Non-Hodgkin…

• CLINICAL_TRIALS research · 2006-10-11
  Clinical Trial Update: Dual Time Point PET Imaging in Lymphoma

  This is a clinical trial update evaluating dual time point PET imaging in Hodgkin lymphoma and non-Hodgkin lymphoma. The current trial statu…